<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Girish P Joshi, MB, BS, MD, FFARCSI
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Roberta Hines, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Nancy A Nussmeier, MD, FAHA
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 23, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H450749872">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multimodal, multidisciplinary fast-track surgery, also known as enhanced recovery after surgery (ERAS) or enhanced recovery pathways (ERPs), can hasten functional recovery after various types of surgical procedures [
         <a href="#rid1">
          1
         </a>
         ]. ERAS/ERP protocols involve evidence-based therapeutic interventions in the preoperative, intraoperative, and postoperative periods [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p>
         This topic discusses management of components (elements) of anesthetic care for enhanced recovery after major abdominal surgical procedures such as gastrointestinal surgery (eg, colorectal surgery, liver resection, gastrectomy, pancreaticoduodenal surgery). Many of the principles discussed in this topic are applicable to other types of major surgical procedures such as urologic surgery (eg, radical nephrectomy and cystectomy), orthopedic surgery (eg, total joint replacement, complex spine surgery), or breast surgery (eg, radical mastectomy).
        </p>
        <p>
         Other topics discuss anesthetic management for enhanced recovery after cardiothoracic surgical procedures. (See
         <a class="medical medical_review" href="/z/d/html/138418.html" rel="external">
          "Anesthetic management for enhanced recovery after thoracic surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/126472.html" rel="external">
          "Anesthetic management for enhanced recovery after cardiac surgery (ERACS)"
         </a>
         .)
        </p>
        <p>
         Details regarding surgical management of enhanced recovery after colorectal surgery or gynecologic surgery are found in separate topics. (See
         <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">
          "Enhanced recovery after colorectal surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/113714.html" rel="external">
          "Enhanced recovery after gynecologic surgery: Components and implementation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H911660903">
         <span class="h1">
          DEFINITION OF ERAS
         </span>
         <span class="headingEndMark">
          —
         </span>
         ERAS refers to evidence-based protocols that standardize care to minimize surgical stress response and postoperative pain, reduce complications, improve outcomes, decrease hospital length of stay, and expedite recovery following elective procedures.
        </p>
        <p>
         The overall principles of perioperative care for major surgical procedures, particularly preoperative and intraoperative management, remain the same with a few procedure-specific variations (eg, procedure-specific pain management). (See
         <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">
          "Enhanced recovery after colorectal surgery", section on 'Elements of ERAS'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/113714.html" rel="external">
          "Enhanced recovery after gynecologic surgery: Components and implementation", section on 'Definition'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H606847595">
         <span class="h1">
          ERAS ELEMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         This table provides an overview of ERAS elements (interventions) (
         <a class="graphic graphic_table graphicRef127176" href="/z/d/graphic/127176.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Early ERAS protocols in 1990s proposed approximately 20 perioperative elements, which were selected based on the evidence obtained in other surgical settings. Subsequent studies suggested that not all ERAS elements are equally weighted for influence on postoperative complications and recovery [
         <a href="#rid3">
          3
         </a>
         ]. For example, in patients undergoing colorectal surgery, intraoperative minimally invasive approaches and postoperative elements such as early oral intake and early ambulation had the greatest impact to speed recovery [
         <a href="#rid4">
          4,5
         </a>
         ]. However, the overall impact of compliance with ERAS protocols was greatest for procedures performed with an open surgical approach, particularly compliance with postoperative elements [
         <a href="#rid5">
          5
         </a>
         ]. Although achievement of postoperative compliance was more difficult compared with the preoperative and intraoperative phases of ERAS protocols in this study, such postoperative elements may be most important once the surgical stress response has occurred.
        </p>
        <p>
         Several other ERAS elements including preoperative optimization of comorbid conditions, avoiding prolonged preoperative fasting, routine antiemetic prophylaxis, use of opioid-sparing analgesic techniques, maintenance of normothermia, lung-protective mechanical ventilation, antibiotic prophylaxis, and venous thromboembolism (VTE) prophylaxis have become standard of care based on extensive evidence [
         <a href="#rid3">
          3
         </a>
         ]. These elements are briefly discussed below, and further detail can be found in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">
          "Preoperative evaluation for anesthesia for noncardiac surgery"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">
          "Preoperative fasting in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Prevention'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1335.html" rel="external">
          "Prevention of venous thromboembolism in adults undergoing hip fracture repair or hip or knee replacement"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Other perioperative ERAS elements such as avoidance of mechanical bowel preparation, carbohydrate loading, goal-directed fluid management, or use of epidural analgesia may be unnecessary [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3553091597">
         <span class="h1">
          PREOPERATIVE CONSIDERATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2361859820">
         <span class="h2">
          Preanesthesia consultation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important goals during the preanesthesia consultation are to [
         <a href="#rid6">
          6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify comorbidities and opportunities to optimize the patient's preoperative condition, which may improve postoperative outcomes. (See
         <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">
          "Preoperative evaluation for anesthesia for noncardiac surgery", section on 'Patient risk factors'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94539.html" rel="external">
          "Preoperative evaluation for anesthesia for noncardiac surgery", section on 'Conditions that increase perioperative risk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Emphasize minimizing the fasting period and maintaining hydration during the fasting period. For example, ERAS protocols for patients undergoing colorectal surgery include advice to patients to hydrate during the fasting period, with consumption of two glasses of water prior to going to bed and two glasses of water before traveling to the hospital on the morning of surgery. There is no evidence that restriction of the volume of clear liquids is beneficial [
         <a href="#rid7">
          7
         </a>
         ]. However, we do not use complex carbohydrate loading, as the evidence of benefit in the ERAS setting is weak [
         <a href="#rid8">
          8
         </a>
         ]. Rather, patients are given an option to consume a simple carbohydrate drink (eg, apple juice or Gatorade) instead of two glasses of water, but the drink must be consumed at least two hours prior to surgery. (See
         <a class="medical medical_review" href="/z/d/html/15698.html" rel="external">
          "Preoperative fasting in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">
          "Enhanced recovery after colorectal surgery", section on 'Fasting guidelines'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Educate the patient and family to set expectations regarding the patient's own role in the recovery process, and reduce patient anxiety. In particular, preoperative planning for pain management emphasizes realistic expectations regarding postoperative pain relief [
         <a href="#rid6">
          6,9-11
         </a>
         ]. Such efforts lead to increased patient satisfaction [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="local">
          'Postoperative anesthetic management'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         Prehabilitation efforts such as nutritional supplementation, physical exercise programs, interventions to improve cognitive function, smoking cessation, and stress reduction are addressed separately. (See
         <a class="medical medical_review" href="/z/d/html/120301.html" rel="external">
          "Overview of prehabilitation for surgical patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3232169428">
         <span class="h2">
          Medications administered in the preoperative period
         </span>
         <span class="headingEndMark">
          —
         </span>
         Medications administered in the immediate preoperative period include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         1 g, administered at least two hours preoperatively if there are no contraindications.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral cyclooxygenase (COX)-2 specific inhibitor (eg,
         <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">
          celecoxib
         </a>
         400 mg) at least two hours preoperatively, if no contraindications.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For selected patients undergoing surgical procedures with a high likelihood of persistent postoperative pain, oral
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         300 to 600 mg may also be administered at least two hours preoperatively [
         <a href="#rid12">
          12,13
         </a>
         ]. However, we avoid gabapentin in patients who are &gt;65 years old or have sleep-disordered breathing (eg, obstructive sleep apnea) due to concerns regarding excessive sedation, ventilatory depression, and dizziness, particularly if gabapentin is combined with opioids [
         <a href="#rid14">
          14-17
         </a>
         ]. In a 2020 meta-analysis of nearly 25,000 patients participating in 281 trials, gabapentinoids were associated with reductions in pain intensity that were clinically insignificant at 6, 12, 24, and 48 postoperative hours, with no effect by 72 postoperative hours, compared with controls who did not receive gabapentinoids [
         <a href="#rid17">
          17
         </a>
         ]. Postoperative nausea and vomiting (PONV) occurred less frequently in patients receiving gabapentinoids (risk ratio [RR] 0.77, 95% CI 0.72-0.82; 17,145 participants). However, a higher incidence of dizziness was noted after gabapentinoid administration (risk ratio [RR] 1.25, 95% CI 1.13-1.39; 12,054 participants) [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For selected surgical procedures, thromboprophylaxis with subcutaneous heparin 5000 units, administered 30 to 60 minutes before surgery. Prophylaxis also includes placement of bilateral sequential compression devices prior to induction of anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients", section on 'Selecting thromboprophylaxis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1335.html" rel="external">
          "Prevention of venous thromboembolism in adults undergoing hip fracture repair or hip or knee replacement"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We avoid routine administration of benzodiazepine premedication. Many anesthesiologists administer a small intravenous (IV) dose of a benzodiazepine, typically
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         1 to 2 mg, just before transfer of the patient from the holding area to the operating room. Perceived benefits include anxiolysis, sedation, amnesia, and improved patient satisfaction [
         <a href="#rid18">
          18
         </a>
         ], although these benefits are controversial [
         <a href="#rid19">
          19
         </a>
         ]. Potential adverse effects of benzodiazepines include postoperative amnesia, drowsiness, and cognitive dysfunction [
         <a href="#rid20">
          20
         </a>
         ], increased incidence of pharyngeal dysfunction and discoordinated breathing and swallowing [
         <a href="#rid21">
          21,22
         </a>
         ], and occasional unpredictable paradoxical reactions (eg, irritability, aggressiveness, delirium) [
         <a href="#rid23">
          23-25
         </a>
         ]. In one large randomized trial in 1062 adults &lt;70 years of age, premedication with a long-acting benzodiazepine (
         <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">
          lorazepam
         </a>
         ) was associated with modestly prolonged time to tracheal extubation, delayed cognitive recovery, and no improvement in self-reported postoperative patient experiences [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2526748191">
         <span class="h1">
          INTRAOPERATIVE ANESTHETIC MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anesthetic agents and techniques are selected to provide optimal operating conditions with consistent and rapid recovery of cognition and physical functions such as oral intake and ambulation, ideally with minimal or no adverse effects. Other aspects of perioperative ERAS management protocols that are managed by anesthesiologists include fluid administration, temperature control, mechanical ventilation, and prophylaxis against pain and nausea/vomiting can affect both short- and long-term postoperative outcomes [
         <a href="#rid2">
          2,27-29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H272906940">
         <span class="h2">
          Induction of anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Major surgical procedures are typically performed under general anesthesia. For ERAS protocols, an intravenous (IV) anesthetic induction sequence is typically used including IV
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         approximately 0.5 to 1 mcg/kg ideal body weight (IBW), given three to five minutes prior to
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         20 to 30 mg, followed by
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         1 to 1.5 mg/kg to achieve loss of eyelash reflex and/or response to verbal command. In addition, a nondepolarizing neuromuscular blocking agent (NMBA) such as
         <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">
          rocuronium
         </a>
         0.6 to 1 mg/kg IBW may be administered to provide muscle relaxation that facilitates laryngoscopy and insertion of an endotracheal tube (ETT). As with other intraoperative settings, it may be necessary to modify selection and dosing of anesthetic induction agents due to patient-specific factors (eg, difficult airway, aspiration risk). (See
         <a class="medical medical_review" href="/z/d/html/94135.html" rel="external">
          "Induction of general anesthesia: Overview"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intravenous induction agents
         </strong>
         –
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          Propofol
         </a>
         is usually the IV induction agent of choice for ERAS protocols due to its unique recovery profile, antiemetic properties, and euphoria on emergence.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Commonly used adjuvants include
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         to minimize the pain associated with
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         injection and an opioid (usually
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         ) to blunt the sympathetic responses to laryngoscopy and tracheal intubation as well as reduce the propofol dose required to achieve loss of consciousness [
         <a href="#rid30">
          30,31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94135.html" rel="external">
          "Induction of general anesthesia: Overview", section on 'Intravenous anesthetic induction'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Dosing of anesthetic induction agents and adjuvants should be judicious; large bolus doses may result in significant post-induction hypotension and need for vasopressor support [
         <a href="#rid32">
          32,33
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">
          "General anesthesia: Intravenous induction agents", section on 'Dosing considerations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94532.html" rel="external">
          "Hemodynamic management during anesthesia in adults", section on 'Selection and dosing of anesthetic agents'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neuromuscular blocking agents
         </strong>
         – An intermediate-acting non-depolarizing NMBA such as
         <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">
          rocuronium
         </a>
         is typically selected for the induction sequence. In patients with a high risk for pulmonary aspiration or a potentially difficult airway, we select
         <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">
          succinylcholine
         </a>
         if there are no contraindications. Further details regarding selection of a muscle relaxant for use during induction are available in separate topics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94135.html" rel="external">
          "Induction of general anesthesia: Overview", section on 'Neuromuscular blocking agents'
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">
          "Clinical use of neuromuscular blocking agents in anesthesia", section on 'Endotracheal intubation'
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">
          "Clinical use of neuromuscular blocking agents in anesthesia", section on 'Adverse effects of succinylcholine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1043323230">
         <span class="h2">
          Antibiotic prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Routine IV antibiotic prophylaxis is administered 30 to 60 minutes before the surgical incision as standard of care. To achieve this timing goal, we typically administer prophylactic antibiotics immediately after induction of general anesthesia. The choice and dose of the antibiotics are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4043.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1012725307">
         <span class="h2">
          Maintenance of anesthesia
         </span>
        </p>
        <p class="headingAnchor" id="H2082250100">
         <span class="h3">
          Inhalation versus total intravenous anesthesia techniques
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maintenance of general anesthesia using either inhalation anesthesia or a total intravenous anesthesia (TIVA) technique is acceptable for patients participating in ERAS protocols. For either technique, it is prudent to use short-acting agents administered at the lowest possible doses since residual effects of inhalation anesthetics and IV hypnotic-sedatives, opioids, and muscle relaxants can delay recovery or result in other adverse effects. Goals for emergence from general anesthesia include planning a rapid clearheaded awakening, with adequate analgesia. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Inhalation anesthetic agents and techniques'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Total intravenous anesthesia'
         </a>
         .)
        </p>
        <p>
         However, we avoid deep levels of general anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Anesthetic depth'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Inhalation anesthesia
         </strong>
         – For most patients, we prefer an inhalation-based technique with a potent volatile agent (
         <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">
          desflurane
         </a>
         or
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         ) plus
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         (N
         <sub>
          2
         </sub>
         O) 50 percent in oxygen to achieve an age-adjusted minimum alveolar concentration (MAC) value of approximately 0.8 to 1.0. (See
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'MAC and MAC-awake values for inhalation agents'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Advantages of the potent volatile inhalation anesthetics include (see
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Some degree of muscle relaxation, allowing minimized dosing of NMBA. (See
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Skeletal and smooth muscle relaxation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ease of titration. (See
         <a class="medical medical_review" href="/z/d/html/94534.html" rel="external">
          "Inhalation anesthetic agents: Properties and delivery", section on 'Factors affecting inhalation anesthetic delivery'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Availability of end-tidal anesthetic concentration (ETAC) to aid in maintenance of adequate anesthetic depth without awareness. We set alarms to detect low ETAC (eg, age-adjusted MAC &lt;0.7). Also, we sometimes employ neuromonitoring such as processed electroencephalography (EEG) such as the bispectral index [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/400.html" rel="external">
          "Accidental awareness during general anesthesia", section on 'End-tidal anesthetic concentration'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/400.html" rel="external">
          "Accidental awareness during general anesthesia", section on 'Brain monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         However, there is insufficient evidence to recommend use of EEG monitoring to prevent postoperative delirium or other neurocognitive disorders [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/118691.html" rel="external">
          "Perioperative neurocognitive disorders in adults: Risk factors and mitigation strategies", section on 'Avoid excessive depth during general anesthesia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Continuum of effect: sedation to general anesthesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rapid recovery, particularly with use of the short-acting inhalation anesthetics (
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         or
         <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">
          desflurane
         </a>
         plus N
         <sub>
          2
         </sub>
         O) [
         <a href="#rid35">
          35
         </a>
         ]. Clinical differences between desflurane and sevoflurane appear to be small, although several studies have reported slightly more rapid emergence with desflurane [
         <a href="#rid36">
          36,37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Sevoflurane'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Desflurane'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Total intravenous anesthesia
         </strong>
         – A TIVA technique may be employed in selected patients participating in an ERAS protocol, particularly those at very high risk for postoperative nausea and vomiting (PONV) [
         <a href="#rid38">
          38
         </a>
         ]. Although a propofol-based TIVA technique may result in a reduced incidence of PONV compared with inhalation anesthesia [
         <a href="#rid39">
          39,40
         </a>
         ], data are not consistent. One 2016 meta-analysis found no overall difference in risk of PONV when TIVA was compared with an inhalation technique if at least one prophylactic antiemetic agent was administered [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Prevention'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A typical TIVA technique includes infusion of
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         75 to 150 mcg/kg/minute, with titration based on neuromonitoring of the processed or unprocessed EEG, with alarms set to detect high EEG indices that indicate possible awareness. A
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         infusion is typically selected for the opioid component of a TIVA technique for ERAS procedures, with titration to achieve hemodynamic stability. (See
         <a class="medical medical_review" href="/z/d/html/96308.html" rel="external">
          "Maintenance of general anesthesia: Overview", section on 'Total intravenous anesthesia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/400.html" rel="external">
          "Accidental awareness during general anesthesia", section on 'Brain monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3888812260">
         <span class="h3">
          Nitrous oxide
         </span>
         <span class="headingEndMark">
          —
         </span>
         We routinely use N
         <sub>
          2
         </sub>
         O for ERAS procedures. The amnestic and analgesic properties of N
         <sub>
          2
         </sub>
         O reduce the requirements of other anesthetic and adjuvant agents [
         <a href="#rid42">
          42
         </a>
         ]. Furthermore, N
         <sub>
          2
         </sub>
         O facilitates both uptake and removal of the potent volatile inhalation anesthetics via its "second gas effect," thereby allowing rapid changes in anesthetic depth and rapid emergence from anesthesia [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Advantages'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94534.html" rel="external">
          "Inhalation anesthetic agents: Properties and delivery", section on 'Second gas effect'
         </a>
         .)
        </p>
        <p>
         Despite these beneficial effects, some clinicians avoid N
         <sub>
          2
         </sub>
         O due to concerns regarding increased risk of PONV. However, the emetic effects of N
         <sub>
          2
         </sub>
         O can be mitigated with use of prophylactic antiemetics [
         <a href="#rid43">
          43-46
         </a>
         ]. Other concerns include the possibility of bowel distention during colorectal procedures due to expansion of closed spaces. However, several studies have noted that surgeons do not recognize a difference between conditions in patients receiving N
         <sub>
          2
         </sub>
         O during colorectal surgery compared with patients not receiving N
         <sub>
          2
         </sub>
         O [
         <a href="#rid47">
          47-49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/114826.html" rel="external">
          "Inhalation anesthetic agents: Clinical effects and uses", section on 'Disadvantages and adverse effects'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2877574991">
         <span class="h3">
          Opioids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Opioids may increase risk for postoperative opioid-related adverse events such as nausea, vomiting, sedation, bladder dysfunction, and respiratory depression, and may increase potential for acute tolerance, delayed hyperalgesia, and paradoxical increases in postoperative pain and opioid dosing requirements [
         <a href="#rid50">
          50,51
         </a>
         ]. Therefore, we avoid high doses of opioids and use opioid-sparing approaches to perioperative pain management. (See
         <a class="medical medical_review" href="/z/d/html/94536.html" rel="external">
          "Perioperative uses of intravenous opioids in adults: General considerations", section on 'Prevention and management of adverse opioid effects'
         </a>
         .)
        </p>
        <p>
         As noted above, a
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         infusion is typically selected for the opioid component of a TIVA technique. For other techniques, small bolus doses of an opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         25 to 50 mcg) may be administered during the intraoperative period if indicated (eg, when increased heart rate and/or blood pressure are noted), but we typically limit the dose (eg, ≤1 mcg/kg per hour of fentanyl). Once fentanyl requirements have exceeded 1 mcg/kg per hour, we typically treat hypertension (and/or tachycardia) with vasoactive agents such as beta blockers or vasodilators rather than with additional doses of an opioid.
        </p>
        <p>
         Notably, intraoperative tachycardia and hypertension often occur due to causes other than pain. For example, during laparoscopic surgical procedures, factors such as increased intra-abdominal pressure, absorption of carbon dioxide (CO
         <sub>
          2
         </sub>
         ), and effects of surgical positioning may lead to tachycardia and/or hypertension. Increasing opioid dosing to treat such hyperdynamic responses is not appropriate, as discussed in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/94355.html" rel="external">
          "Anesthesia for patients with hypertension", section on 'Prevention and treatment of intraoperative hypertension'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2313057756">
         <span class="h3">
          Neuromuscular blocking agents
         </span>
         <span class="headingEndMark">
          —
         </span>
         An NMBA is often administered to facilitate surgical exposure during laparoscopic or open surgical procedures [
         <a href="#rid52">
          52,53
         </a>
         ]. We avoid profound muscle paralysis by using a peripheral nerve stimulator to aim for a moderate level of neuromuscular blockade during laparoscopic procedures (eg, a train-of-four [TOF] count of 2 to 3). Even during laparoscopic abdominal surgery, we administer NMBAs as required by the clinical situation, aiming for the least degree of block necessary for the clinical situation. Detailed discussions regarding dosing and monitoring the effects of NMBAs are found in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">
          "Clinical use of neuromuscular blocking agents in anesthesia", section on 'Facilitation of surgery'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/114324.html" rel="external">
          "Monitoring neuromuscular blockade", section on 'Train-of-four'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/100120.html" rel="external">
          "Anesthesia for laparoscopic and abdominal robotic surgery in adults", section on 'Neuromuscular blockade'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         We avoid maintenance of deep neuromuscular blockade as this results in use of high doses of NMBAs and increased risk of residual muscle weakness at the end of the procedure (defined as a TOF ratio &lt;0.9), even after reversal [
         <a href="#rid54">
          54-56
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">
          "Clinical use of neuromuscular blocking agents in anesthesia", section on 'Avoidance of residual neuromuscular blockade'
         </a>
         ). Furthermore, one study noted that persistent impairment of the peripheral chemoreflex with blunting of the ventilatory response to hypoxia often occurs despite complete reversal of
         <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">
          rocuronium
         </a>
         with
         <a class="drug drug_general" data-topicid="9693" href="/z/d/drug information/9693.html" rel="external">
          neostigmine
         </a>
         or
         <a class="drug drug_general" data-topicid="105866" href="/z/d/drug information/105866.html" rel="external">
          sugammadex
         </a>
         [
         <a href="#rid57">
          57
         </a>
         ]. These effects may increase the risk for serious adverse respiratory events [
         <a href="#rid55">
          55,58
         </a>
         ]. Approaches to reducing residual effects of NMBAs include using the smallest dose of an NMBA that provides optimal surgical conditions, avoiding use of long-acting NMBAs, and ensuring complete reversal of any residual neuromuscular blockade near the end of the surgical procedure. Dosing of the reversal agents neostigmine or sugammadex is based on the degree of residual neuromuscular block at the time the agent is administered. Details regarding timing and adequacy of reversal of neuromuscular block are found in separate topics:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94537.html" rel="external">
          "Emergence from general anesthesia", section on 'Assess and reverse effects of neuromuscular blocking agents'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94535.html" rel="external">
          "Clinical use of neuromuscular blocking agents in anesthesia", section on 'Reversal of neuromuscular block'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/94348.html" rel="external">
          "Respiratory problems in the post-anesthesia care unit (PACU)", section on 'Neuromuscular blocking agents'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2309437483">
         <span class="h2">
          Mechanical ventilation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative lung protective mechanical ventilation reduces postoperative pulmonary complications, length of hospital stay, and mortality after major surgery [
         <a href="#rid59">
          59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1598.html" rel="external">
          "Ventilator-induced lung injury"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1628.html" rel="external">
          "Clinical and physiologic complications of mechanical ventilation: Overview"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintenance phase of general anesthesia
         </strong>
         – Optimal lung protective parameters include (see
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Low tidal volumes (ie, 6 to 8 mL/kg IBW). (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Tidal volume'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Initial positive end-expiratory pressure (PEEP) 5 cm H
         <sub>
          2
         </sub>
         O (or 8 to 10 cm H
         <sub>
          2
         </sub>
         O during laparoscopic procedures). However, as surgery progresses, PEEP should be individualized based on patient and surgical factors, in an attempt to avoid both alveolar overdistention and atelectasis. In addition to patients undergoing laparoscopic procedures, those who are obese or undergoing surgery performed in steep Trendelenburg position may need levels of PEEP &gt;5 cm H
         <sub>
          2
         </sub>
         O. (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Positive end-expiratory pressure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Individualized PEEP'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Plateau pressure ≤16 mmHg and driving pressure (defined as the difference between plateau pressure and PEEP) ≤16 mmHg. (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Plateau pressure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Driving pressure'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Monitoring driving pressure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) 0.4 to 0.5. (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Fraction of inspired oxygen'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Initial respiratory rate of 8 breaths/minute, subsequently adjusted to maintain end-tidal carbon dioxide (ETCO
         <sub>
          2
         </sub>
         ) levels at approximately 40 mmHg (rather than traditional values of 30 to 35 mmHg). These higher CO
         <sub>
          2
         </sub>
         level may increase tissue perfusion and oxygenation, due to an increase in cardiac output and vasodilation, and a rightward shift of the oxyhemoglobin dissociation curve. (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Respiratory rate'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Goal end-tidal carbon dioxide'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Performance of recruitment maneuvers only when indicated to improve oxygenation (eg, in an obese patient), or in specific circumstances (eg, after insufflation for laparoscopy or disconnection from the ventilator for suctioning). (See
         <a class="medical medical_review" href="/z/d/html/93386.html" rel="external">
          "Mechanical ventilation during anesthesia in adults", section on 'Recruitment maneuvers'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         During laparoscopic procedures, high peak airway pressures and/or desaturation may necessitate temporary modifications in these ventilator settings. (See
         <a class="medical medical_review" href="/z/d/html/100120.html" rel="external">
          "Anesthesia for laparoscopic and abdominal robotic surgery in adults", section on 'Mechanical ventilation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Emergence from general anesthesia
         </strong>
         – During emergence, we maintain minute ventilation in an effort to eliminate inhalation anesthetics and facilitate rapid emergence. Although some clinicians reduce the respiratory rate near the end of the procedure in an effort to increase ETCO
         <sub>
          2
         </sub>
         levels to simulate respiration, this reduction of respiratory rate and minute ventilation can delay removal of inhalation anesthetic agents, thereby delaying emergence. (See
         <a class="medical medical_review" href="/z/d/html/94537.html" rel="external">
          "Emergence from general anesthesia", section on 'Preparations for emergence'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H244926194">
         <span class="h2">
          Fluid management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intraoperative fluid management is aimed at restoring and maintaining euvolemia. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Choosing a fluid management strategy'
         </a>
         .)
        </p>
        <p>
         We typically use a zero-balance fluid therapy approach that minimizes fluid administration for minimally or moderately invasive surgery for patients participating in an ERAS protocol. We administer a balanced electrolyte solution (eg, Ringer's lactate) at 3 mL/kg/hour. We do not "preload" fluid prior to neuraxial block or induction of general anesthesia, or replace urine output, calculated insensible losses, or nonanatomic "third space" losses [
         <a href="#rid60">
          60
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Restrictive (zero-balance) strategy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Minimally/moderately invasive surgery'
         </a>
         .)
        </p>
        <p>
         For high-risk patients undergoing major surgical procedures that dictate arterial catheter placement, this approach is supplemented with goal-directed fluid therapy, particularly if significant blood losses (eg, &gt;500 mL) and/or fluid shifts are expected. With this approach, supplemental fluid boluses (typically 200 to 250 mL) are administered based on information derived from invasive dynamic hemodynamic parameters such as manual estimation or automated calculation of variations in systolic blood pressure or pulse pressure in the intraarterial waveform tracing, or variations in stroke volume. Further details are available in a separate topic:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Major invasive surgery'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Goal-directed fluid therapy'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Dynamic parameters to assess volume responsiveness'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         For patients participating in ERAS protocols and other surgical patients, evidence suggests that these fluid management strategies (zero-balance or goal-directed approaches) are superior to traditional approaches that use liberal fluid administration based on a fixed volume resulting in administration of excessive volumes of crystalloid solution and increased risk for tissue edema and associated adverse outcomes. (See
         <a class="medical medical_review" href="/z/d/html/14942.html" rel="external">
          "Intraoperative fluid management", section on 'Avoid traditional liberal or fixed-volume approaches'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H497236349">
         <span class="h2">
          Temperature control
         </span>
         <span class="headingEndMark">
          —
         </span>
         Core body temperature is routinely monitored at the esophageal or nasopharyngeal site, and warming devices are employed to maintain normothermia (temperature ≥35.5°C) [
         <a href="#rid61">
          61-64
         </a>
         ]. These include upper- and lower-body forced-air warming devices and blankets, insulation water mattresses, and devices for warming all IV fluids. (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Intraoperative hypothermia'
         </a>
         .)
        </p>
        <p>
         Hypothermia is avoided because of potential complications in the immediate- and long-term postoperative periods (eg, shivering, coagulopathy, prolonged duration of stay in the post-anesthesia care unit (PACU), surgical site infection, adverse cardiac events) [
         <a href="#rid64">
          64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94588.html" rel="external">
          "Perioperative temperature management", section on 'Postoperative temperature derangements'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1125347342">
         <span class="h2">
          Glycemic control
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perioperative glycemic control is initiated in the preoperative period, including appropriate advice to diabetic patients regarding hypoglycemic drugs and insulin administration. Perioperative blood glucose levels are monitored and maintained between 140 and 200 mg/dL (7.8 to 11 mmol/L) in both diabetic and nondiabetic patients throughout the perioperative period. More aggressive control is avoided as this incurs risk of hypoglycemia and associated perioperative complications. (See
         <a class="medical medical_review" href="/z/d/html/1753.html" rel="external">
          "Perioperative management of blood glucose in adults with diabetes mellitus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4078456404">
         <span class="h2">
          Antiemetic prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         We routinely use multimodal antiemetic prophylaxis in all patients participating in ERAS protocols to facilitate early recovery [
         <a href="#rid38">
          38
         </a>
         ]. Although selective risk-based approaches for antiemetic therapy have been proposed, compliance with these strategies may be poor [
         <a href="#rid65">
          65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Risk stratification'
         </a>
         .)
        </p>
        <p>
         We typically use a combination of IV
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         8 to 10 mg administered after induction of anesthesia, as well as a 5-hydroxytryptamine type 3 (5-HT3) antagonist such as IV
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         4 mg administered at the end of the surgical procedure. Administration of a higher perioperative dose of dexamethasone 0.2 mg/kg did not reduce a composite of serious complications (eg, organ failure) compared with placebo in a trial of more than 1200 patients undergoing major noncardiac surgery, but increased risk for hyperglycemia requiring insulin therapy [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
         For patients at very high risk of PONV (eg, history of motion sickness, history of previous PONV, known high opioid requirements for pain relief), we administer an additional antiemetic agent such as preoperative transdermal
         <a class="drug drug_general" data-topicid="9915" href="/z/d/drug information/9915.html" rel="external">
          scopolamine
         </a>
         or intraoperative IV
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         0.5 to 1 mg administered shortly after induction of anesthesia. Notably, use of more than three antiemetics has not been shown to confer additional clinical benefit [
         <a href="#rid67">
          67
         </a>
         ]. In addition, a TIVA technique may be used for such high-risk patients. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting", section on 'Antiemetics'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H909429008">
         <span class="h2">
          Pain prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postoperative multimodal pain management is patient-specific and procedure-specific, with the goal of minimizing pain during rest and also during early mobilization and physical therapy. Combinations of the following agents and techniques may be used to balance analgesic efficacy with overall side effects in multimodal strategies [
         <a href="#rid13">
          13
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Creating a plan for analgesia'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonopioid analgesics
         </strong>
         – We employ combinations of
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and a nonsteroidal antiinflammatory drug (NSAID) or a cyclooxygenase (COX)-2 specific inhibitor in multimodal pain management protocols for all patients who have no contraindications (see
         <a class="medical medical_review" href="/z/d/html/7991.html" rel="external">
          "Nonselective NSAIDs: Overview of adverse effects"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/91242.html" rel="external">
          "Anesthesia for the patient with liver disease", section on 'Other analgesics'
         </a>
         ) [
         <a href="#rid13">
          13,68-71
         </a>
         ]. We typically administer oral acetaminophen two hours preoperatively; IV acetaminophen 1 g is administered after induction of anesthesia only if the patient did not receive preoperative acetaminophen.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Administration of NSAIDs is typically avoided until the surgical procedure itself has been completed (late during the intraoperative period or in the postoperative period) due to antiplatelet effects that may increase risk of perioperative bleeding. We typically administer IV
         <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">
          ketorolac
         </a>
         15 to 30 mg (if no contraindications) near the end of the surgical procedure. However, COX-2 specific inhibitors spare the COX-1 enzyme and have no antiplatelet effects; thus, these agents may be administered earlier (in the preoperative period) if desired. Oral or IV preparations of
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and NSAIDs or COX-2 specific inhibitors are then continued in the postoperative period with regular scheduled dosing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although most experts recommend such combinations of an NSAID plus
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         [
         <a href="#rid13">
          13,68
         </a>
         ], only heterogeneous evidence of the efficacy of this approach exists because of differences in the types of surgical procedures studied, specific agents used, and dosing and timing of administration of these agents. One 2013 meta-analysis included three trials with 1647 total patients who received a combination of differing doses of
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         and acetaminophen, ibuprofen alone, or placebo, with agent(s) administered only once in the perioperative period during various types of surgical procedures [
         <a href="#rid69">
          69
         </a>
         ]. The proportion of patients achieving at least 50 percent maximum pain relief over six postoperative hours ranged from 69 to 73 percent with this combination (depending on the dose of each drug) compared with only 7 percent of those receiving placebo, and only 52 percent of those receiving ibuprofen alone. No significant adverse events were reported in any of the included studies [
         <a href="#rid69">
          69
         </a>
         ]. Similarly, an older meta-analysis of 21 trials (2909 patients) that compared acetaminophen alone or in combination with one of several NSAIDs (ibuprofen,
         <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">
          diclofenac
         </a>
         ,
         <a class="drug drug_general" data-topicid="8590" href="/z/d/drug information/8590.html" rel="external">
          ketoprofen
         </a>
         ,
         <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">
          ketorolac
         </a>
         ,
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         ,
         <a class="drug drug_general" data-topicid="110865" href="/z/d/drug information/110865.html" rel="external">
          tenoxicam
         </a>
         , or rofecoxib), noted that combinations of these agents were more effective than either agent alone [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional considerations regarding administration of NSAIDs and
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         are discussed in other sections of this topic and elsewhere:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="local">
          'Medications administered in the preoperative period'
         </a>
         above.)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="local">
          'Management of pain'
         </a>
         below.)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults", section on 'Acetaminophen'
         </a>
         .)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults", section on 'Nonsteroidal anti-inflammatory drugs'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Local or regional anesthetic techniques
         </strong>
         – A local or regional anesthetic technique is often employed as a primary component of a multimodal analgesic regimen [
         <a href="#rid13">
          13,72,73
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Local infiltration or surgical field block
         </strong>
         – Infiltration of the surgical wound with local anesthetic provides excellent analgesia that outlasts the duration of action of the drug; therefore, this technique is used whenever possible [
         <a href="#rid74">
          74
         </a>
         ]. Attention to proper infiltration technique (ie, infiltration into the peritoneal, musculofascial, and subdermal tissue planes) is essential to attain the maximum benefits. Catheters may be placed by the surgeon directly at the site of the incision and can be left in place for days [
         <a href="#rid73">
          73
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Wound infiltration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         An alternative is an interfascial plane block such as the transversus abdominis plane (TAP) blocks, which provide excellent pain relief after laparoscopic or open lower (below the umbilicus) abdominal surgical procedures such as total abdominal hysterectomy. However, a TAP block is unlikely to be superior to surgical site infiltration after a laparoscopic procedure with a small incision [
         <a href="#rid72">
          72
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/122399.html" rel="external">
          "Transversus abdominis plane (TAP) blocks procedure guide"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         New interfascial plane blocks are emerging (eg, quadratus lumborum, serratus plane, and erector spinae plane blocks). Erector spinae plane blocks provide somatic as well as visceral analgesia, and may be superior to peripheral interfascial plane blocks (eg, the TAP block) [
         <a href="#rid72">
          72
         </a>
         ]. Details regarding placement of these blocks are available in separate topics:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/138905.html" rel="external">
          "Erector spinae plane block procedure guide"
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/100071.html" rel="external">
          "Thoracic nerve block techniques", section on 'Serratus plane block'
         </a>
         .)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/132540.html" rel="external">
          "Quadratus lumborum block procedure guide"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Some clinicians use long-acting
         <a class="drug drug_general" data-topicid="17057" href="/z/d/drug information/17057.html" rel="external">
          liposomal bupivacaine
         </a>
         , which has been approved by the US Food and Drug Administration, for local infiltration at the surgical wound site. (See
         <a class="medical medical_review" href="/z/d/html/14929.html" rel="external">
          "Clinical use of local anesthetics in anesthesia", section on 'Sustained release bupivacaine'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Peripheral nerve blocks
         </strong>
         – Peripheral nerve blocks for the lower extremity (eg, femoral nerve block) are not used commonly due to concern regarding delays in ambulation and recovery. Furthermore, since single injection peripheral nerve blocks have a short duration of action, rebound pain may occur after the block has resolved. However, brachial plexus blocks are still used for upper extremity surgery, and popliteal sciatic nerve block are suitable for selected foot and ankle procedures [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/130312.html" rel="external">
          "Approach to the management of acute pain in adults", section on 'Regional anesthesia techniques'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Neuraxial analgesia
         </strong>
         – We do not use epidural analgesia in ERAS patients undergoing minimally invasive procedures (eg, laparoscopic surgery) because of potential delays in ambulation and hospital discharge due to adverse side effects that may include postural hypotension, need for a urinary catheter, or inadequate muscle strength. Also, there is little additional benefit for pain control since alternative analgesic techniques provide similar pain relief (eg, interfascial plane blocks) [
         <a href="#rid13">
          13
         </a>
         ]. In particular, we avoid administration of an intrathecal opioid such as
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         for any ERAS procedure due to high risk for adverse effects including nausea, vomiting, pruritus, urinary retention, and respiratory depression.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Although epidural analgesia provides excellent pain relief after major open thoracic and abdominal surgical procedures, it is unnecessary after less invasive surgical approaches [
         <a href="#rid13">
          13
         </a>
         ]. Rarely, thoracic epidural analgesia is used to prevent or treat pain after an open procedure with a long midline incision (eg, from the xiphoid process to the pubis). Such use is typically supplemented with a TAP block for the subumbilical portion of the incision.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fixed dose of a long-acting opioid
         </strong>
         – For patients who did not receive a regional anesthetic technique, ERAS protocols include a precalculated dose of a long-acting opioid for most open surgical procedures. We use
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         0.05 to 0.1 mg/kg IBW or
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         5 to 10 mcg/kg IBW administered approximately 20 minutes prior to the expected time of extubation (eg, when the surgeon starts closing the abdomen). This approach does not delay awakening or tracheal extubation [
         <a href="#rid75">
          75
         </a>
         ]. Some clinicians attempt to titrate a long-acting opioid to produce a respiratory rate of approximately 12 to 15 breaths per minute during emergence from anesthesia, but potential residual effects of anesthetic agents and NMBAs make this approach challenging.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Long-acting opioids are always used sparingly due to opioid-related adverse effects that delay recovery and return to activities of daily living (eg, delayed emergence from anesthesia, postoperative respiratory depression, delirium, PONV, urinary retention necessitating bladder catheterization, pruritus, development of acute tolerance or hyperalgesia) [
         <a href="#rid25">
          25,50,51
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/94536.html" rel="external">
          "Perioperative uses of intravenous opioids in adults: General considerations", section on 'Dosing considerations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94536.html" rel="external">
          "Perioperative uses of intravenous opioids in adults: General considerations", section on 'Prevention and management of adverse opioid effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adjunct agents
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Dexamethasone
         </strong>
         – As noted above, we routinely administer IV
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         8 to 10 mg after induction of anesthesia to all patients unless there are contraindications, due to its antiemetic prophylactic effects (see
         <a class="local">
          'Antiemetic prophylaxis'
         </a>
         above), but it also has analgesic properties [
         <a href="#rid76">
          76,77
         </a>
         ]. Potential concerns regarding increases in blood glucose and surgical site infections have not been observed in large observational studies [
         <a href="#rid78">
          78,79
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Ketamine
         </strong>
         – We do not routinely use intraoperative
         <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">
          ketamine
         </a>
         to achieve postoperative analgesia. Although administration of a low dose of ketamine (25 to 50 mg) after induction of anesthesia has been reported to improve postoperative pain relief [
         <a href="#rid80">
          80
         </a>
         ], adverse psychotomimetic effects such as hallucinations, nightmares, or vivid dreams during and shortly after emergence from anesthesia limit its use in ERAS protocols [
         <a href="#rid13">
          13,81,82
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2165741456">
         <span class="h1">
          POSTOPERATIVE ANESTHETIC MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postoperative goals in ERAS protocols include prevention and relief of pain and postoperative nausea or vomiting (PONV), as well as facilitation of early nutrition and mobilization [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1830785956">
         <span class="h2">
          Management of pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         While the patient is in the post-anesthesia care unit (PACU), pain is treated with small bolus doses of either intravenous (IV)
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         1 to 2 mg doses (up to 10 mg) or IV
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         0.1 to 0.2 mg (up to 1 mg).
        </p>
        <p>
         Subsequently, we use scheduled doses of oral
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         1 g four times per day and an oral nonsteroidal antiinflammatory drug (NSAID; eg,
         <a class="drug drug_general" data-topicid="10295" href="/z/d/drug information/10295.html" rel="external">
          meloxicam
         </a>
         15 mg once per day) or oral cyclooxygenase (COX)-2 specific inhibitor (eg,
         <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">
          celecoxib
         </a>
         200 mg twice per day) [
         <a href="#rid13">
          13,68-70
         </a>
         ]. For patients who do not yet tolerate oral liquids, acetaminophen,
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         , and
         <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">
          ketorolac
         </a>
         are each available in an IV formulation. (See
         <a class="medical medical_review" href="/z/d/html/133187.html" rel="external">
          "Nonopioid pharmacotherapy for acute pain in adults"
         </a>
         .)
        </p>
        <p>
         For major open surgical procedures with a high likelihood of persistent postoperative pain, we also use oral
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         300 mg three times per day [
         <a href="#rid12">
          12,13
         </a>
         ]. As noted above (see
         <a class="local">
          'Medications administered in the preoperative period'
         </a>
         above), we avoid gabapentin in older patients and those with sleep-disordered breathing (eg, obstructive sleep apnea) due to concerns regarding excessive sedation, ventilatory depression, and dizziness [
         <a href="#rid14">
          14-17
         </a>
         ].
        </p>
        <p>
         We administer oral
         <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">
          oxycodone
         </a>
         5 to 10 mg four times per day as needed for breakthrough pain. For patients unable to take oxycodone, we use
         <a class="drug drug_general" data-topicid="10010" href="/z/d/drug information/10010.html" rel="external">
          tramadol
         </a>
         50 mg four times per day as needed. If a patient is unable to take oral medications or has severe pain, small bolus doses of IV
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         (2 to 3 mg) or
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         (0.5 mg) may be administered as needed. In rare circumstances, it may be necessary to administer IV opioids via IV patient-controlled analgesia to achieve control of postoperative pain. (See
         <a class="medical medical_review" href="/z/d/html/134254.html" rel="external">
          "Use of opioids for postoperative pain control"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4243497461">
         <span class="h2">
          Management of nausea and vomiting
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients requiring postoperative rescue antiemetic therapy to treat PONV, we typically administer IV
         <a class="drug drug_general" data-topicid="9820" href="/z/d/drug information/9820.html" rel="external">
          promethazine
         </a>
         6.25 mg and/or
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         4 mg (no earlier than four hours after an intraoperative ondansetron dose) and/or
         <a class="drug drug_general" data-topicid="8896" href="/z/d/drug information/8896.html" rel="external">
          dimenhydrinate
         </a>
         1 mg/kg. (See
         <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">
          "Postoperative nausea and vomiting"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1310524537">
         <span class="h2">
          Observation for cardiopulmonary problems
         </span>
         <span class="headingEndMark">
          —
         </span>
         Even after minimally invasive surgery and adherence to an ERAS protocol, observation and prompt treatment of postoperative problems such as hypoxemia or orthostatic hypotension is necessary [
         <a href="#rid84">
          84,85
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3965677478">
         <span class="h1">
          OUTCOMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data from observational studies and randomized trials in patients undergoing colorectal surgery show that ERAS protocols are associated with reduced hospital length of stay and morbidity, reduced postoperative pain, faster recovery, comparable or reduced readmission rate, and cost savings compared with traditional care. Adherence to a standardized ERAS protocol impacts outcomes such as complications and length of hospital stay [
         <a href="#rid27">
          27,86,87
         </a>
         ]. Further discussion regarding these outcomes is available in a separate topic. (See
         <a class="medical medical_review" href="/z/d/html/15006.html" rel="external">
          "Enhanced recovery after colorectal surgery", section on 'Outcomes'
         </a>
         .)
        </p>
        <p>
         Similarly, studies in various types of gynecologic surgery have noted that ERAS protocols are associated with decreased pain, length of stay, use of nursing time, and overall costs, thereby improving patient satisfaction and quality of life. (See
         <a class="medical medical_review" href="/z/d/html/113714.html" rel="external">
          "Enhanced recovery after gynecologic surgery: Components and implementation", section on 'Outcomes'
         </a>
         .)
        </p>
        <p>
         Short- and long-term postoperative outcomes are influenced by anesthesia-related management as part of a multidisciplinary team effort during the preoperative, intraoperative, and postoperative periods [
         <a href="#rid3">
          3,6,28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3244356381">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/116124.html" rel="external">
          "Society guideline links: Postoperative nausea and vomiting"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/122843.html" rel="external">
          "Society guideline links: Enhanced recovery after surgery"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H200683127">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative considerations
         </strong>
         – Management to facilitate enhanced recovery after surgery (ERAS) emphasizes (
         <a class="graphic graphic_table graphicRef127176" href="/z/d/graphic/127176.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Preoperative considerations'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Identifying comorbidities and opportunities to optimize preoperative condition
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Minimizing the fasting period and maintaining hydration during the fasting period
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Educating patient and family to reduce patient anxiety and set realistic expectations, particularly regarding plans for pain management
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative medications
         </strong>
         – Medications for ERAS protocols given in the preoperative period typically include oral
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         1 g and a cyclooxygenase (COX)-2 specific inhibitor (eg,
         <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">
          celecoxib
         </a>
         400 mg) administered at least two hours preoperatively for patients without contraindications to these agents. Oral
         <a class="drug drug_general" data-topicid="8483" href="/z/d/drug information/8483.html" rel="external">
          gabapentin
         </a>
         is reserved for selected patients undergoing surgical procedures with a high risk of persistent postoperative pain (300 to 600 mg administered at least two hours preoperatively). Also, thromboprophylaxis with subcutaneous heparin 5000 units is administered 30 to 60 minutes before surgery. We avoid routine administration of benzodiazepine premedication. (See
         <a class="local">
          'Medications administered in the preoperative period'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic induction
         </strong>
         – A typical anesthetic induction sequence includes intravenous (IV)
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         approximately 0.5 to 1 mcg/kg ideal body weight (IBW), given three to five minutes prior to
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         20 to 30 mg, followed by
         <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">
          propofol
         </a>
         1 to 1.5 mg/kg to achieve loss of eyelash reflex and/or response to verbal command. In addition, a nondepolarizing neuromuscular blocking agent (NMBA) such as
         <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">
          rocuronium
         </a>
         0.6 to 1 mg/kg IBW may be administered to facilitate laryngoscopy and endotracheal intubation. (See
         <a class="local">
          'Induction of anesthesia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anesthetic maintenance
         </strong>
         – During maintenance of anesthesia, we prefer an inhalation-based technique with a potent volatile agent (
         <a class="drug drug_general" data-topicid="8891" href="/z/d/drug information/8891.html" rel="external">
          desflurane
         </a>
         or
         <a class="drug drug_general" data-topicid="9887" href="/z/d/drug information/9887.html" rel="external">
          sevoflurane
         </a>
         ) and
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         (N
         <sub>
          2
         </sub>
         O) 50 percent in oxygen to achieve an age-adjusted minimum alveolar concentration (MAC) value of approximately 0.8 to 1.0, and we avoid deep anesthesia. A total intravenous anesthesia (TIVA) technique is a reasonable alternative for selected patients (eg, those at very high risk for postoperative nausea and vomiting [PONV]). (See
         <a class="local">
          'Inhalation versus total intravenous anesthesia techniques'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We use short-acting agents administered at the lowest possible doses:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Small bolus doses of an opioid (eg,
         <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">
          fentanyl
         </a>
         25 to 50 mcg) may be administered as needed, but we typically limit the dose (eg, ≤1 mcg/kg per hour fentanyl). For TIVA techniques, a
         <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">
          remifentanil
         </a>
         infusion is typically selected for the opioid component. (See
         <a class="local">
          'Opioids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We routinely use N
         <sub>
          2
         </sub>
         O for ERAS procedures. Its amnestic and analgesic properties reduce the requirements of other anesthetic and adjuvant agents, and its "second gas effect" facilitates both uptake and removal of the potent volatile inhalation anesthetics. (See
         <a class="local">
          'Nitrous oxide'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An NMBA is often administered to facilitate surgical exposure, but we monitor the effects of the NMBA with a peripheral nerve stimulator to avoid profound muscle paralysis. (See
         <a class="local">
          'Neuromuscular blocking agents'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lung-protective ventilation
         </strong>
         – We use lung protective ventilatory parameters including low tidal volumes (ie, 6 to 8 mL/kg IBW), initial positive end-expiratory pressure (PEEP) 5 cm H
         <sub>
          2
         </sub>
         O (or 8 to 10 cm H
         <sub>
          2
         </sub>
         O during laparoscopic procedures), plateau pressures ≤16 mmHg, driving pressure (defined as the difference between plateau pressure and PEEP) ≤16 mmHg, fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) 0.4 to 0.5, and an initial respiratory rate of 8 breaths/minute, subsequently adjusted to maintain end-tidal carbon dioxide (ETCO
         <sub>
          2
         </sub>
         ) levels at approximately 40 mmHg. (See
         <a class="local">
          'Mechanical ventilation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluid management
         </strong>
         – We typically use a zero-balance fluid therapy approach that minimizes fluid administration for minimally or moderately invasive surgery with administration of a balanced electrolyte solution at 3 mL/kg/hour. For high-risk patients undergoing major surgical procedures, this approach is supplemented with goal-directed fluid therapy with administration of fluid boluses (typically 200 to 250 mL) based on dynamic hemodynamic parameters. (See
         <a class="local">
          'Fluid management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maintenance of normothermia
         </strong>
         – Core body temperature is routinely monitored and warming devices are employed to maintain normothermia (temperature ≥35.5°C). (See
         <a class="local">
          'Temperature control'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Glycemic control
         </strong>
         – Perioperative blood glucose levels are monitored and maintained between 140 and 200 mg/dL (7.8 to 11 mmol/L) in both diabetic and nondiabetic patients. (See
         <a class="local">
          'Glycemic control'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antiemetic prophylaxis
         </strong>
         – Antiemetic prophylaxis includes IV
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         8 to 10 mg after induction of anesthesia and
         <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">
          ondansetron
         </a>
         4 mg at the end of surgery. For patients at very high risk of PONV, we add a third antiemetic (eg, preoperative transdermal
         <a class="drug drug_general" data-topicid="9915" href="/z/d/drug information/9915.html" rel="external">
          scopolamine
         </a>
         patch or intraoperative IV
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         0.5 to 1 mg shortly after induction). Postoperative rescue antiemetic therapy to treat PONV includes IV
         <a class="drug drug_general" data-topicid="9820" href="/z/d/drug information/9820.html" rel="external">
          promethazine
         </a>
         6.25 mg and/or ondansetron 4 mg (no earlier than four hours after an intraoperative ondansetron dose) and/or
         <a class="drug drug_general" data-topicid="8896" href="/z/d/drug information/8896.html" rel="external">
          dimenhydrinate
         </a>
         1 mg/kg. (See
         <a class="local">
          'Antiemetic prophylaxis'
         </a>
         above and
         <a class="local">
          'Management of nausea and vomiting'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multimodal pain management
         </strong>
         – We employ intraoperative and postoperative multimodal pain prophylaxis and management strategies that minimize perioperative opioid use including (see
         <a class="local">
          'Pain prophylaxis'
         </a>
         above and
         <a class="local">
          'Management of pain'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest administration of a combination of
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         and a nonsteroidal antiinflammatory drug (NSAID) or a COX-2 specific inhibitor (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). We typically administer acetaminophen 1 g IV shortly after induction of anesthesia (if not previously administered in the preoperative period), as well as a NSAID such as
         <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">
          ketorolac
         </a>
         15 to 30 mg IV at the end of surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Local or regional techniques, such as surgical site infiltration and interfascial plane blocks. However, we avoid epidural analgesia and intrathecal
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         because of potential delays in ambulation and hospital discharge without additional benefits for pain control.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients undergoing open procedures without a regional anesthetic technique, administration of a precalculated dose of a long-acting opioid approximately 20 minutes before extubation (eg,
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         0.05 to 0.1 mg/kg IBW or
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         5 to 10 mcg/kg IBW).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For pain while the patient is in the post-anesthesia care unit (PACU), administration of small bolus doses of either IV
         <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">
          morphine
         </a>
         1 to 2 mg doses (up to 10 mg) or IV
         <a class="drug drug_general" data-topicid="8538" href="/z/d/drug information/8538.html" rel="external">
          hydromorphone
         </a>
         0.1 to 0.2 mg (up to 1 mg).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Subsequently, we use scheduled doses of oral
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         1 g four times per day and an oral NSAID (eg,
         <a class="drug drug_general" data-topicid="10295" href="/z/d/drug information/10295.html" rel="external">
          meloxicam
         </a>
         15 mg once per day) or oral COX-2 specific inhibitor (eg,
         <a class="drug drug_general" data-topicid="8847" href="/z/d/drug information/8847.html" rel="external">
          celecoxib
         </a>
         200 mg twice per day). For patients who do not yet tolerate oral liquids, acetaminophen,
         <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">
          ibuprofen
         </a>
         , and
         <a class="drug drug_general" data-topicid="8591" href="/z/d/drug information/8591.html" rel="external">
          ketorolac
         </a>
         are each available in an IV formulation.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008; 248:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kehlet H, Joshi GP. Enhanced Recovery After Surgery: Current Controversies and Concerns. Anesth Analg 2017; 125:2154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Kehlet H. Enhanced Recovery Pathways: Looking Into the Future. Anesth Analg 2019; 128:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pecorelli N, Hershorn O, Baldini G, et al. Impact of adherence to care pathway interventions on recovery following bowel resection within an established enhanced recovery program. Surg Endosc 2017; 31:1760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aarts MA, Rotstein OD, Pearsall EA, et al. Postoperative ERAS Interventions Have the Greatest Impact on Optimal Recovery: Experience With Implementation of ERAS Across Multiple Hospitals. Ann Surg 2018; 267:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nilsson U, Gruen R, Myles PS. Postoperative recovery: the importance of the team. Anaesthesia 2020; 75 Suppl 1:e158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brady M, Kinn S, Stuart P. Preoperative fasting for adults to prevent perioperative complications. Cochrane Database Syst Rev 2003; :CD004423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amer MA, Smith MD, Herbison GP, et al. Network meta-analysis of the effect of preoperative carbohydrate loading on recovery after elective surgery. Br J Surg 2017; 104:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee BH, Wu CL. Educating Patients Regarding Pain Management and Safe Opioid Use After Surgery: A Narrative Review. Anesth Analg 2020; 130:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horn A, Kaneshiro K, Tsui BCH. Preemptive and Preventive Pain Psychoeducation and Its Potential Application as a Multimodal Perioperative Pain Control Option: A Systematic Review. Anesth Analg 2020; 130:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hah J, Mackey SC, Schmidt P, et al. Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial. JAMA Surg 2018; 153:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Kehlet H. Postoperative pain management in the era of ERAS: An overview. Best Pract Res Clin Anaesthesiol 2019; 33:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fabritius ML, Geisler A, Petersen PL, et al. Gabapentin for post-operative pain management - a systematic review with meta-analyses and trial sequential analyses. Acta Anaesthesiol Scand 2016; 60:1188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cavalcante AN, Sprung J, Schroeder DR, Weingarten TN. Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression. Anesth Analg 2017; 125:141.
          </a>
         </li>
         <li class="breakAll">
          FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR). US Food and Drug Administration 2019. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin (Accessed on January 24, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verret M, Lauzier F, Zarychanski R, et al. Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-analysis. Anesthesiology 2020; 133:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bauer KP, Dom PM, Ramirez AM, O'Flaherty JE. Preoperative intravenous midazolam: benefits beyond anxiolysis. J Clin Anesth 2004; 16:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bucx MJ, Krijtenburg P, Kox M. Preoperative use of anxiolytic-sedative agents; are we on the right track? J Clin Anesth 2016; 33:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers JF, Morrison AL, Nafziger AN, et al. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics. Clin Pharmacol Ther 2002; 72:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hårdemark Cedborg AI, Sundman E, Bodén K, et al. Effects of morphine and midazolam on pharyngeal function, airway protection, and coordination of breathing and swallowing in healthy adults. Anesthesiology 2015; 122:1253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petroianni A, Ceccarelli D, Conti V, Terzano C. Aspiration pneumonia. Pathophysiological aspects, prevention and management. A review. Panminerva Med 2006; 48:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004; 24:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepousé C, Lautner CA, Liu L, et al. Emergence delirium in adults in the post-anaesthesia care unit. Br J Anaesth 2006; 96:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes CG, Boncyk CS, Culley DJ, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention. Anesth Analg 2020; 130:1572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maurice-Szamburski A, Auquier P, Viarre-Oreal V, et al. Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial. JAMA 2015; 313:916.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grant MC, Pio Roda CM, Canner JK, et al. The Impact of Anesthesia-Influenced Process Measure Compliance on Length of Stay: Results From an Enhanced Recovery After Surgery for Colorectal Surgery Cohort. Anesth Analg 2019; 128:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sessler DI. Long-term consequences of anesthetic management. Anesthesiology 2009; 111:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ban KA, Gibbons MM, Ko CY, et al. Evidence Review Conducted for the Agency for Healthcare Research and Quality Safety Program for Improving Surgical Care and Recovery: Focus on Anesthesiology for Colorectal Surgery. Anesth Analg 2019; 128:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan FA, Ullah H. Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database Syst Rev 2013; :CD004087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith C, McEwan AI, Jhaveri R, et al. The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81:820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salmasi V, Maheshwari K, Yang D, et al. Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis. Anesthesiology 2017; 126:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Südfeld S, Brechnitz S, Wagner JY, et al. Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth 2017; 119:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan MTV, Hedrick TL, Egan TD, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Electroencephalography. Anesth Analg 2020; 130:1278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller TE, Gan TJ. Total intravenous anesthesia and anesthetic outcomes. J Cardiothorac Vasc Anesth 2015; 29 Suppl 1:S11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jakobsson J. Desflurane: a clinical update of a third-generation inhaled anaesthetic. Acta Anaesthesiol Scand 2012; 56:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dexter F, Bayman EO, Epstein RH. Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane. Anesth Analg 2010; 110:570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg 2020; 131:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sneyd JR, Carr A, Byrom WD, Bilski AJ. A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol 1998; 15:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaefer MS, Kranke P, Weibel S, et al. Total intravenous anaesthesia versus single-drug pharmacological antiemetic prophylaxis in adults: A systematic review and meta-analysis. Eur J Anaesthesiol 2016; 33:750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Vasconcellos K, Sneyd JR. Nitrous oxide: are we still in equipoise? A qualitative review of current controversies. Br J Anaesth 2013; 111:877.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buhre W, Disma N, Hendrickx J, et al. European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice. Br J Anaesth 2019; 122:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Guisasola J, Gómez-Arnau JI, Cabrera Y, del Valle SG. Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis. Anaesthesia 2010; 65:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Myles PS, Chan MT, Kasza J, et al. Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II Trial. Anesthesiology 2016; 124:1032.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Pennant JH, Kehlet H. Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia (ENIGMA) Studies: The Tale of Two Large Pragmatic Randomized Controlled Trials. Anesth Analg 2017; 124:2077.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor E, Feinstein R, White PF, Soper N. Anesthesia for laparoscopic cholecystectomy. Is nitrous oxide contraindicated? Anesthesiology 1992; 76:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krogh B, Jørn Jensen P, Henneberg SW, et al. Nitrous oxide does not influence operating conditions or postoperative course in colonic surgery. Br J Anaesth 1994; 72:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brodsky JB, Lemmens HJ, Collins JS, et al. Nitrous oxide and laparoscopic bariatric surgery. Obes Surg 2005; 15:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu CL, King AB, Geiger TM, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients. Anesth Analg 2019; 129:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexander JC, Patel B, Joshi GP. Perioperative use of opioids: Current controversies and concerns. Best Pract Res Clin Anaesthesiol 2019; 33:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madsen MV, Staehr-Rye AK, Claudius C, Gätke MR. Is deep neuromuscular blockade beneficial in laparoscopic surgery? Yes, probably. Acta Anaesthesiol Scand 2016; 60:710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruintjes MH, van Helden EV, Braat AE, et al. Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis. Br J Anaesth 2017; 118:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brull SJ, Kopman AF. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology 2017; 126:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart PA, Liang SS, Li QS, et al. The Impact of Residual Neuromuscular Blockade, Oversedation, and Hypothermia on Adverse Respiratory Events in a Postanesthetic Care Unit: A Prospective Study of Prevalence, Predictors, and Outcomes. Anesth Analg 2016; 123:859.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saager L, Maiese EM, Bash LD, et al. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study. J Clin Anesth 2019; 55:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Broens SJL, Boon M, Martini CH, et al. Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers. Anesthesiology 2019; 131:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandit JJ, Eriksson LI. Reversing Neuromuscular Blockade: Not Just the Diaphragm, but Carotid Body Function Too. Anesthesiology 2019; 131:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young CC, Harris EM, Vacchiano C, et al. Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations. Br J Anaesth 2019; 123:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Kehlet H. CON: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol? Anesth Analg 2016; 122:1261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           John M, Ford J, Harper M. Peri-operative warming devices: performance and clinical application. Anaesthesia 2014; 69:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perl T, Bräuer A, Quintel M. Prevention of perioperative hypothermia with forced-air warming systems and upper-body blankets. Surg Technol Int 2006; 15:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madrid E, Urrútia G, Roqué i Figuls M, et al. Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults. Cochrane Database Syst Rev 2016; 4:CD009016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sessler DI. Perioperative thermoregulation and heat balance. Lancet 2016; 387:2655.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kappen TH, Vergouwe Y, van Wolfswinkel L, et al. Impact of adding therapeutic recommendations to risk assessments from a prediction model for postoperative nausea and vomiting. Br J Anaesth 2015; 114:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asehnoune K, Le Moal C, Lebuffe G, et al. Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial. BMJ 2021; 373:n1162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 2012; 109:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Bonnet F, Kehlet H, PROSPECT collaboration. Evidence-based postoperative pain management after laparoscopic colorectal surgery. Colorectal Dis 2013; 15:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Derry CJ, Derry S, Moore RA. Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain. Cochrane Database Syst Rev 2013; 2013:CD010210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thybo KH, Hägi-Pedersen D, Dahl JB, et al. Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty: The PANSAID Randomized Clinical Trial. JAMA 2019; 321:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 2010; 110:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machi A, Joshi GP. Interfascial plane blocks. Best Pract Res Clin Anaesthesiol 2019; 33:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Machi A. Surgical site infiltration: A neuroanatomical approach. Best Pract Res Clin Anaesthesiol 2019; 33:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Joshi GP, Janis JE, Haas EM, et al. Surgical Site Infiltration for Abdominal Surgery: A Novel Neuroanatomical-based Approach. Plast Reconstr Surg Glob Open 2016; 4:e1181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aubrun F, Amour J, Rosenthal D, et al. Effects of a loading dose of morphine before i.v. morphine titration for postoperative pain relief: a randomized, double-blind, placebo-control study. Br J Anaesth 2007; 98:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Oliveira GS Jr, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 2011; 115:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Oliveira GS Jr, Thran M. Dexamethasone: The wonder drug in perioperative medicine. J Clin Anesth 2017; 43:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toner AJ, Ganeshanathan V, Chan MT, et al. Safety of Perioperative Glucocorticoids in Elective Noncardiac Surgery: A Systematic Review and Meta-analysis. Anesthesiology 2017; 126:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corcoran T, Kasza J, Short TG, et al. Intraoperative dexamethasone does not increase the risk of postoperative wound infection: a propensity score-matched post hoc analysis of the ENIGMA-II trial (EnDEX). Br J Anaesth 2017; 118:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riddell JM, Trummel JM, Onakpoya IJ. Low-dose ketamine in painful orthopaedic surgery: a systematic review and meta-analysis. Br J Anaesth 2019; 123:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowdle TA, Radant AD, Cowley DS, et al. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998; 88:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleinloog D, Uit den Boogaard A, Dahan A, et al. Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers. J Psychopharmacol 2015; 29:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg 2017; 152:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bojesen RD, Fitzgerald P, Munk-Madsen P, et al. Hypoxaemia during recovery after surgery for colorectal cancer: a prospective observational study. Anaesthesia 2019; 74:1009.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eriksen JR, Munk-Madsen P, Kehlet H, Gögenur I. Orthostatic intolerance in enhanced recovery laparoscopic colorectal resection. Acta Anaesthesiol Scand 2019; 63:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu JY, Wick EC. Enhanced Recovery After Surgery and Effects on Quality Metrics. Surg Clin North Am 2018; 98:1119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arrick L, Mayson K, Hong T, Warnock G. Enhanced recovery after surgery in colorectal surgery: Impact of protocol adherence on patient outcomes. J Clin Anesth 2019; 55:7.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 113724 Version 27.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18650627" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Evidence-based surgical care and the evolution of fast-track surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29190219" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Enhanced Recovery After Surgery: Current Controversies and Concerns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30550467" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Enhanced Recovery Pathways: Looking Into the Future.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27538934" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Impact of adherence to care pathway interventions on recovery following bowel resection within an established enhanced recovery program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29303803" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Postoperative ERAS Interventions Have the Greatest Impact on Optimal Recovery: Experience With Implementation of ERAS Across Multiple Hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31903575" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Postoperative recovery: the importance of the team.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14584013" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Preoperative fasting for adults to prevent perioperative complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28000931" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Network meta-analysis of the effect of preoperative carbohydrate loading on recovery after elective surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26827847" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31567320" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Educating Patients Regarding Pain Management and Safe Opioid Use After Surgery: A Narrative Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31335400" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Preemptive and Preventive Pain Psychoeducation and Its Potential Application as a Multimodal Perioperative Pain Control Option: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29238824" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785712" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Postoperative pain management in the era of ERAS: An overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27426431" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Gabapentin for post-operative pain management - a systematic review with meta-analyses and trial sequential analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27984223" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27984223" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32667154" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15217656" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Preoperative intravenous midazolam: benefits beyond anxiolysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27555147" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Preoperative use of anxiolytic-sedative agents; are we on the right track?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12496752" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25853450" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Effects of morphine and midazolam on pharyngeal function, airway protection, and coordination of breathing and swallowing in healthy adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17215795" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Aspiration pneumonia. Pathophysiological aspects, prevention and management. A review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15460178" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Paradoxical reactions to benzodiazepines: literature review and treatment options.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16670111" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Emergence delirium in adults in the post-anaesthesia care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32022748" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25734733" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29782405" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The Impact of Anesthesia-Influenced Process Measure Compliance on Length of Stay: Results From an Enhanced Recovery After Surgery for Colorectal Surgery Cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19512884" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Long-term consequences of anesthetic management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29649026" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Evidence Review Conducted for the Agency for Healthcare Research and Quality Safety Program for Improving Surgical Care and Recovery: Focus on Anesthesiology for Colorectal Surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23824697" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7943832" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The interaction of fentanyl on the Cp50 of propofol for loss of consciousness and skin incision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27792044" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Relationship between Intraoperative Hypotension, Defined by Either Reduction from Baseline or Absolute Thresholds, and Acute Kidney and Myocardial Injury after Noncardiac Surgery: A Retrospective Cohort Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28974066" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31764163" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on the Role of Neuromonitoring in Perioperative Outcomes: Electroencephalography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26025040" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Total intravenous anesthesia and anesthetic outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22188283" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Desflurane: a clinical update of a third-generation inhaled anaesthetic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19820242" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32467512" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12067003" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9699101" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27454663" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Total intravenous anaesthesia versus single-drug pharmacological antiemetic prophylaxis in adults: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23801743" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Nitrous oxide: are we still in equipoise? A qualitative review of current controversies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30916011" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20151955" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26904965" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Severe Nausea and Vomiting in the Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia II Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28181932" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Evaluation of Nitrous Oxide in the Gas Mixture for Anesthesia (ENIGMA) Studies: The Tale of Two Large Pragmatic Randomized Controlled Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1550279" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Anesthesia for laparoscopic cholecystectomy. Is nitrous oxide contraindicated?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8110552" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Nitrous oxide does not influence operating conditions or postoperative course in colonic surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15946427" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Nitrous oxide and laparoscopic bariatric surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31082966" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Opioid Minimization in Opioid-Naïve Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785719" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Perioperative use of opioids: Current controversies and concerns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26864853" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Is deep neuromuscular blockade beneficial in laparoscopic surgery? Yes, probably.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28575335" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Deep neuromuscular block to optimize surgical space conditions during laparoscopic surgery: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27820709" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27537929" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The Impact of Residual Neuromuscular Blockade, Oversedation, and Hypothermia on Adverse Respiratory Events in a Postanesthetic Care Unit: A Prospective Study of Prevalence, Predictors, and Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30594097" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31045894" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31206374" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Reversing Neuromuscular Blockade: Not Just the Diaphragm, but Carotid Body Function Too.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31587835" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Lung-protective ventilation for the surgical patient: international expert panel-based consensus recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27101489" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : CON: Perioperative Goal-Directed Fluid Therapy Is an Essential Element of an Enhanced Recovery Protocol?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24720346" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Peri-operative warming devices: performance and clinical application.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17029156" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Prevention of perioperative hypothermia with forced-air warming systems and upper-body blankets.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27098439" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26775126" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Perioperative thermoregulation and heat balance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25274048" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Impact of adding therapeutic recommendations to risk assessments from a prediction model for postoperative nausea and vomiting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34078591" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23035051" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Evidence-based analysis of risk factors for postoperative nausea and vomiting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23350836" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Evidence-based postoperative pain management after laparoscopic colorectal surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23794268" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30747964" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty: The PANSAID Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20142348" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785716" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Interfascial plane blocks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31785717" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Surgical site infiltration: A neuroanatomical approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28293525" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Surgical Site Infiltration for Abdominal Surgery: A Novel Neuroanatomical-based Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17065166" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Effects of a loading dose of morphine before i.v. morphine titration for postoperative pain relief: a randomized, double-blind, placebo-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21799397" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29079408" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Dexamethasone: The wonder drug in perioperative medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27922839" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Safety of Perioperative Glucocorticoids in Elective Noncardiac Surgery: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28100522" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Intraoperative dexamethasone does not increase the risk of postoperative wound infection: a propensity score-matched post hoc analysis of the ENIGMA-II trial (EnDEX).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31327465" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Low-dose ketamine in painful orthopaedic surgery: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9447860" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25693889" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28564673" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31099028" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Hypoxaemia during recovery after surgery for colorectal cancer: a prospective observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30094811" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Orthostatic intolerance in enhanced recovery laparoscopic colorectal resection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30390846" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Enhanced Recovery After Surgery and Effects on Quality Metrics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30583114" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Enhanced recovery after surgery in colorectal surgery: Impact of protocol adherence on patient outcomes.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
